| scholarly article | Q13442814 |
| P50 | author | Angelique J.A. Kooper | Q89414470 |
| Ilse Feenstra | Q92869044 | ||
| Brigitte H. W. Faas | Q130284899 | ||
| P2093 | author name string | Merel C van Maarle | |
| Erik A Sistermans | |||
| Lidewij Henneman | |||
| Sander Bollen | |||
| Dick Oepkes | |||
| Marjan M Weiss | |||
| Rutger W W Brouwer | |||
| Diane Van Opstal | |||
| Robert-Jan H Galjaard | |||
| Stijn Ghesquiere | |||
| Karin Huijsdens-van Amsterdam | |||
| Roy Straver | |||
| Nicolette den Hollander | |||
| Mariette J V Hoffer | |||
| Gita M Tan-Sindhunata | |||
| Lean Beulen | |||
| Shama L Bhola | |||
| Lutgarde Govaerts | |||
| Heleen Schuring-Blom | |||
| Martin G Elferink | |||
| Klaske Lichtenbelt | |||
| Merryn V Macville | |||
| Godelieve C Page-Christiaens | |||
| P2860 | cites work | False Negative NIPT Results: Risk Figures for Chromosomes 13, 18 and 21 Based on Chorionic Villi Results in 5967 Cases and Literature Review | Q26771694 |
| Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis | Q28072788 | ||
| European collaborative research on mosaicism in CVS (EUCROMIC)--fetal and extrafetal cell lineages in 192 gestations with CVS mosaicism involving single autosomal trisomy | Q28236672 | ||
| Confined placental mosaicism for trisomies 2, 3, 7, 8, 9, 16, and 22: their incidence, likely origins, and mechanisms for cell lineage compartmentalization | Q28290041 | ||
| Copy-number variation and false positive prenatal aneuploidy screening results | Q30643919 | ||
| Confined placental mosaicism and intrauterine fetal growth | Q33589311 | ||
| Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma | Q34336915 | ||
| Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies | Q34484712 | ||
| Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics | Q34535626 | ||
| Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes | Q35936608 | ||
| Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling | Q37345805 | ||
| Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives | Q37557986 | ||
| Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact | Q37558281 | ||
| WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. | Q37631891 | ||
| Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive cases | Q37637591 | ||
| Mosaicism and uniparental disomy in prenatal diagnosis | Q38303197 | ||
| Clinical implementation of NIPT - technical and biological challenges | Q38418240 | ||
| Cytogenetic confirmation of a positive NIPT result: evidence-based choice between chorionic villus sampling and amniocentesis depending on chromosome aberration. | Q38728695 | ||
| The clinical utility of genome-wide non invasive prenatal screening | Q38830275 | ||
| Prenatal and pre-implantation genetic diagnosis | Q38954748 | ||
| Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals | Q38959581 | ||
| Abnormal non-invasive prenatal test results concordant with karyotype of cytotrophoblast but not reflecting abnormal fetal karyotype | Q39019372 | ||
| Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. | Q39024055 | ||
| Confined placental mosaicism and pregnancy outcome: a distinction needs to be made between types 2 and 3. | Q39645871 | ||
| Association of Clinical Cytogeneticists chorion villus sampling database 1987-2000. | Q40343752 | ||
| Trisomy 16 and trisomy 16 Mosaicism: a review | Q41008074 | ||
| Molecular cytogenetic analysis of term placentae suspected of mosaicism using fluorescence in situ hybridization | Q41537810 | ||
| Chorionic villus culture for prenatal diagnosis of chromosome defects: reduction of the long-term cultivation time | Q45102663 | ||
| Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report | Q48004844 | ||
| Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies | Q48374194 | ||
| NIPT-based screening for Down syndrome and beyond: what do pregnant women think? | Q50596773 | ||
| New Dutch reference curves for birthweight by gestational age. | Q51603508 | ||
| Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis | Q56967944 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Confirmation of CVS mosaicism in term placentae and high frequency of intrauterine growth retardation association with confined placental mosaicism | Q67873137 | ||
| Benefits and burdens of using a SNP array in pregnancies at increased risk for the common aneuploidies | Q86279902 | ||
| Maternal Malignancies Detected With Noninvasive Prenatal Testing | Q86779974 | ||
| Cytogenetic follow-up of chromosomal mosaicism detected in first-trimester prenatal diagnosis | Q87450712 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 480-485 | |
| P577 | publication date | 2017-09-28 | |
| P1433 | published in | Genetics in Medicine | Q15765508 |
| P1476 | title | Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study | |
| P478 | volume | 20 |
| Q57055693 | De novo unbalanced translocations have a complex history/aetiology |
| Q98513871 | Genome-wide noninvasive prenatal screening for carriers of balanced reciprocal translocations |
| Q102061414 | High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening |
| Q90555311 | Impact of ultrasonography on identifying noninvasive prenatal screening false-negative aneuploidy |
| Q64077209 | Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin |
| Q92483662 | Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA |
| Q92011829 | Placental studies elucidate discrepancies between NIPT showing a structural chromosome aberration and a differently abnormal fetal karyotype |
| Q98778840 | Prenatal diagnosis of mosaic trisomy 2 and literature review |
| Q55209454 | Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing. |
| Q58564726 | Small supernumerary marker chromosomes: A legacy of trisomy rescue? |
| Q98946480 | Terminal deletion of chromosome 13 in a fetus with normal NIPT: The added value of invasive prenatal diagnosis in the NIPT era |
| Q91130436 | The clinical benefit of genome-wide cfDNA testing cannot be extrapolated from CVS data |
Search more.